Aspiriant LLC
TGT icon

Aspiriant LLC’s Target TGT Stock Holding History

Aspiriant LLC’s Portfolio TGT Stock Details TGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$341K Sell
2,175
-33
-1% -$4.96K 0.01% 295
2026
Q2 		$288K Buy
+2,208
New +$281K 0.01% 327
2025
Q1 		– Sell
-1,618
Closed -$219K – 304
2024
Q4 		$219K Buy
1,618
+152
+10% +$21.8K 0.01% 273
2024
Q3 		$228K Sell
1,466
-210
-13% -$31.3K 0.01% 264
2024
Q2 		$248K Sell
1,676
-641
-28% -$101K 0.01% 254
2024
Q1 		$411K Buy
2,317
+158
+7% +$24K 0.02% 215
2023
Q4 		$307K Buy
2,159
+112
+5% +$13.7K 0.01% 237
2023
Q3 		$226K Buy
2,047
+400
+24% +$50.8K 0.01% 256
2023
Q2 		$217K Sell
1,647
-60
-4% -$8.9K 0.01% 266
2023
Q1 		$283K Buy
1,707
+40
+2% +$6.58K 0.01% 226
2022
Q4 		$248K Buy
1,667
+78
+5% +$12.2K 0.01% 239
2022
Q3 		$235K Buy
1,589
+97
+7% +$15.5K 0.01% 233
2022
Q2 		$211K Sell
1,492
-51
-3% -$9.8K 0.01% 261
2022
Q1 		$327K Sell
1,543
-55
-3% -$11.9K 0.02% 217
2021
Q4 		$371K Buy
1,598
+95
+6% +$23.1K 0.02% 205
2021
Q3 		$344K Sell
1,503
-75
-5% -$18.8K 0.02% 184
2021
Q2 		$380K Sell
1,578
-186
-11% -$40.7K 0.02% 180
2021
Q1 		$351K Sell
1,764
-90
-5% -$16.8K 0.02% 166
2020
Q4 		$327K Sell
1,854
-2,316
-56% -$386K 0.02% 167
2020
Q3 		$656K Buy
+4,170
New +$572K 0.05% 134
2017
Q1 		– Sell
-13,136
Closed -$949K – 225
2016
Q4 		$949K Buy
13,136
+4,451
+51% +$322K 0.09% 111
2016
Q3 		$596K Sell
8,685
-1,322
-13% -$94.8K 0.06% 128
2016
Q2 		$816K Buy
10,007
+2,470
+33% +$184K 0.08% 113
2016
Q1 		$620K Buy
+7,537
New +$569K 0.06% 121

Other funds holding TGT

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Aspiriant LLC's TGT Position: Q3 2026 in Review

Aspiriant LLC reduced its Target (TGT) stake by 1.5% in Q3 2026, selling an estimated $4.96K and leaving 2,175 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #295.

Aspiriant LLC first reported a position in TGT in Q1 2016 and has held it in 24 quarters since. The position peaked at $949K in Q4 2016. 1,351 funds tracked by Wall St. Rank hold TGT as of Q3 2026.

  • Aspiriant LLC held 2,175 shares of Target worth $341K as of Q3 2026.
  • Aspiriant LLC sold 33 Target shares in Q3 2026, an estimated $4.96K.
  • Target made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #295 holding.
  • Aspiriant LLC first reported a position in Target in Q1 2016 and has held it in 24 quarters since.
  • Aspiriant LLC's Target position peaked at $949K in Q4 2016.
  • 1,351 funds tracked by Wall St. Rank held Target as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.